Akèy › Kansè nan tete › Illinois › Evanston
Etid klinik pou Kansè nan tete nan Evanston, IL
13 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Evanston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Advocate Lutheran General Hospital, Park Ridge · 8 mi lwen
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Ap rekriteFaz 1/2
- Orchard Healthcare Research Inc.- Skokie, Skokie · 2 mi lwen
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- Endeavor Health, Evanston
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Ap rekriteEtid obsèvasyon
- Orchard Healthcare Research Inc., Skokie · 2 mi lwen
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Ap rekriteFaz 2
- Orchard Healthcare Research Inc. ( Site 0006), Skokie · 2 mi lwen
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Ap rekriteFaz 1
- NorthShore University Health System - Evanston Hospital, Evanston
- NorthShore University HealthSystem - Evanston Hospital, Evanston
- Orchard Healthcare Research, Skokie · 2 mi lwen
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Ap rekriteFaz 3
- Research Site, Evanston
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- North Shore Medical Center, Skokie · 2 mi lwen
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi lwen
- ak 3 plis
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi lwen
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Ap rekriteFaz 3
- Orchard Healthcare Research Inc., Skokie · 2 mi lwen
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi lwen
- Advocate Lutheran General Hospital, Park Ridge · 8 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Advocate Lutheran General Hospital, Park Ridge · 8 mi lwen
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Ap rekriteEtid obsèvasyon
- Northshore University Health System, Evanston
Etid Kansè nan tete nan lòt vil
- New York City, NY134 etid
- Houston, TX126 etid
- Boston, MA111 etid
- Nashville, TN80 etid
- Los Angeles, CA72 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Durham, NC63 etid
- Queens, NY63 etid
- Chicago, IL58 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Evanston
- Kansè Poumon ki pa ti selil22 etid
- Kansè poumon19 etid
- Leksemi mieloïd egi11 etid
- Obèsite11 etid
- Kansè kolorektal10 etid
- Kansè (tout kalite)9 etid
- Sipwa9 etid
- Kolit Ulseratif9 etid
- Kansè pwostat9 etid
- Maladi Crohn9 etid
- Ensifizyans kadyak8 etid
- Fibrilasyon atriyal8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.